Document:

OUTSIDE DIRECTOR COMPENSATION PLAN

 

Exhibit 10.4

Outside Director Compensation Plan (a)

	 	 	 
	Annual Cash Retainer:
	 	 
	Board Member
	 	$30,000
	 
	 	 
	Audit Committee Chair
	 	$10,000
	Audit Committee Member
	 	No additional compensation
	Compensation Committee Chair
	 	$10,000
	Compensation Committee Member
	 	No additional compensation
	Nominating Committee Chair
	 	No additional compensation
	Nominating Committee Member
	 	No additional compensation
	 
	 	 
	Additional Payments:
	 	 
	Attendance Fee for In Person Attendance at Board Meeting
	 	$1,000
	Attendance Fee for Telephone Attendance at Board Meeting
	 	$500
	Attendance Fee for Committee Meeting Attendance
	 	$500
	 
	 	 
	Equity Grant Upon Initial Election or Appointment
	 	Pro-Rata for Partial Year
	New directors — on the date of initial election
	 	of Service Based on Date
	or appointment to the Board, new directors (other than
	 	of Initial Election or
	directors elected at the annual meeting of stockholders
	 	Appointment, Relative to
	who will receive the annual stock option grant and
	 	the Date of the Preceding
	annual grant of restricted stock as set forth below)
	 	Annual Meeting of
	will be entitled to a pro-rata portion of the annual
	 	Stockholders
	restricted stock award and option grant
	 	 
	 
	 	 
	Annual Stock Option Grant (b)
	 	$80,000
	 
	 	 
	Annual Grant of Restricted Stock (c)
	 	$30,000
	 
	 	 
	Expense Reimbursement — for travel, lodging and other reasonable out-of-pocket
expenses incurred in attending board and committee meetings

 

			
	All amounts listed above are in United States dollars.
	 
	(a)	 	Each member of the Board, other than a director employed by the Company, is entitled to
receive compensation under this plan.
	 
	(b)	 	Each of these options will have an exercise price equal to the fair market value of the
Company’s common stock on the date of grant, a term of 10 years, and will vest 25% per year on
each anniversary of the option grant date for 4 years.
	 
	(c)	 	Each share of restricted stock will be fully vested on the first anniversary of the grant
date.

The number of shares issued for restricted stock awards and option grants shall equal the specified
dollar value of the restricted stock or option award divided by the applicable per share or per
option 123R charge as of the grant date as determined by the company for financial reporting
purposes.

Timing of Director Compensation: Each Director shall receive an initial stock option grant and
restricted stock award the day of the director’s election or appointment to the board. Thereafter,
on the date of each annual meeting of stockholders, each person who is either elected to the Board
at the annual meeting or continues to serve on the Board upon the conclusion of the annual meeting
will receive his or her annual stock option grant and restricted stock award. The cash retainer
and other fees will be paid in arrears, quarterly or semi-annually at the Company’s discretion.EX-4.1

 

	016570| 003590|127C|RESTRICTED||4|057-423
E
COMMON STOCK ................................................................................................... COMMON STOCK
PAR VALUE $.02 THIS CERTIFICATE IS TRANSFERABLE IN            li*vJ ^1N
• • -r^1-^-V4~t            CANTON, MA AND JERSEY CITY, NJ
REIS
• •• •%. ^ I l^» ....................................................................................... fcMW^I ^**^||
i cate •• XXJ-^XV^ ...................... Shares
r • .............................. **60062o****** H
Dflfl .................................................................................................................. ***60o62o***** ;
UUU .................................................................................................................... ****gggg2Q**** tfl
REIS, INC. ............................................................................................................. *****g00620*** j
INCORPORATED UNDER THE LAWS OF THE STATE OF MARYLAND * 6006 20* “
“Mr .Alexander DavidSample — Mr.Alexander David Sample — Mr.Alexander David Sample “Mr .Alexander D9«t SAlB^lefler David Sample            l!l5\S*^J??ft«5?lHE
THIS CERTIFICATE THAT
I nlO            Otr\ I ll~ltO            I l~lr\l            Sample""|Mr.*pS*ider M^W Sftnpfc “J|PrVI|xa ndfl-Ba vkQa mplfc “1| ilPYMBtf der r^T^ Salhp|l"*«|r^lf^irrnHIR-Da*vk1(V^lexander Sfft’S iu’^C-tl-KjUl
D1 >i ^ 4ylWA^ ^ ......................................................................................... rn^TP 7 RQ^^P            ID            R
Alexander laVdMan\lft “-*P*f /GxMbSI II vid simp let-Mr VHra nleV[WvidV Wle""'l»^lJxa*fftllid S^flfcwavltftirnple” .... ^UO-LJT /J^OOJT _LU -J “/W” ^M^i"'•’SAfl

	___O
COL’^? ‘ OKil ‘
ifi-fr
Mr.Alexander DavidSample — Mr.Alexander David
Sample — Mr.Alexander David Sample — Mr.Alexander Da\KJrSAkaptotret David Sample Sjflt-^i. ‘ ‘
tJli’fr ‘ ‘•JtFVi?

	M VJ?^^«flS’MR1l1*Sil “ ** ‘ Alexan(ft J|f“f “C1” ^A^AnPf
1‘1 STTTP1e “O* • ^WaV|FTC*Samp!O” fV A^xaJIfryfVMrSfqBmder David • ..............................
......... • IffiS^WSSSbtfBSSS
<D            i- ''lii^r*TM^!?!^ ( Sample” Mr J\*lhV Da vif**mi||A“l\/l fctefaIder Inu Saflfcle “IV/llnffa B** DavkmMn£**fW|kAl^lB cfrWIr. Alexander            opepcwcpcc FOR CERTAIN DEFINITIOMN            S?ti3W*Pl
S^’£BH^
^ David Sample •l^llAlk^ndeV^^d^JnVlJf^Mr&xlwter Swffltl sJnY|["\Oe» ndCTJC\ln%U-"rMVrtit*Hitie(e “ Mr . SEE REVERSE FOR CERTAIN DEFINITIONS
^— O            Alexander David Sample — Mr.Alexander David Sample — Mr.Alexander David Sample — Mr.Alexander David SAtepte He? Hfflavid Sample —
~ i f^^ff^^&f^’f^’Li.1‘” Mr. Alexander David Sample — Mr .Alexander David Sample — Mr. Alexander David Sample — Mr. Alexander DavM-SSBimfcle” Mr. Sample ^wK^S^^S^^tf?V^.
—
I’ X            I            iS            th0 OWn 0r            Of

	Shares—600620“Shares“600620“Shares“600620“Shares“600620BTOBaffl’eSnfTr es “‘

	SpljwWSt*S^^A 620“Shares“600620“Shares—600620“Shares—600620“Shares—600620“Shares“600620“Shares"'600620“Aha ytt$$$F$*ffi •
Shares —600620“Shares —600620“Shares
“600620“Shares “600620“Shares —600620“Shares
—600620“Share srta-r6MB2feOB620“S            SfiSffS?^?^*S^^Sfe
        .;/•” j
*»V ‘._/ + f. 
ha
r
es
“600620“Shars —600620“Shares “600620“Shares
—600620“Shares“600620“Shares —600620“Shares
‘aT6ffl0620Br®B20“ShaSWt^jfl**V^KnB
f^^^^M FULLY-PAID AND NONASSESSABLE SHARES OF THE COMMON STOCK, $.02 PAR VALUE PER SHARE, OF

 

 

	Rei s, In c. (th e “ Corporation ) s fer able in person or by duly authorized attorney upon surrender of pp^1‘*^^^
-SSSSSS” °^5“a2 certificate properly endorsed. This certificate and the shares represented hereby are issued and shall be subject
^iSSSSSSs §"3i“T> lllr^^^^yii *° a II of the provisions of the charter of the Corporation (the “Charter “), the Bylaws of the Corporation , and a IU-^;;”
IggggggS-S^go            a men dmen ts ther eof and ther eto, cop ies of which s ha II be a va ila ble a t the hea dqua r ter s of Cor p or a tion , a n d to a II
«§§§§§§z ^1? :^>:t^of which the holder by a ccep ta n ce her eof a s s en ts . This cer tifica te is n ot va lid un Ies s coun ter s ign ed by the ;. .
!’<£<£<£<£<£<£§- 3TM Transfer Agen t a n d r egis ter ed by the Regis tr a r .
SSSSSS Witne stfcie fa cs imile s ea I of the Cor p or a tion a n d the fa cs imile s ign a tur es of its duly a uthor ized officer s .
0501-^ooio^i. 23 tt!^-’rff^%ii
•xv/!a///^
?/X’/^X /^
VS.:..’^C\, COUNTERSIGNED AND REGISTERED: l^^f^-’JIll
Z ~ ‘^yl^^^lffi //^/’^“T/ l/// /3**°**>£\ \ COMPUTERSHARE TRUST COMPANY, N.A.R»K*lf Itwl
% *£ xx ‘^^i^’^’^^Sl            Pf es iden t a n d Chief Executive OfficerI / SEAL ‘i ^ ^^^^SsSsH
»rp^-*- !‘N&^ I Vice-Pr es iden t, Chief Fin a n cia I Officer a n d As s is ta n t Seer eta r y authorized signature
^^B 1234567exv10w1

 

Exhibit 10.1

SUBSCRIPTION AGREEMENT

Citizens, Inc.

400 East Anderson Lane

Austin, Texas 78752

The undersigned (the “Investor”) hereby confirms its agreement with you as follows:

1. This Subscription Agreement (this “Agreement”) is made as of the date set forth below between
Citizens, Inc., a Colorado corporation (the “Company”), and the Investor.

2. The Company has authorized the sale and issuance to certain investors of up to 3,200,000 shares
(the “Shares”) of its Class A common stock, no par value (the “Common Stock”), for a purchase price
of $7.00 per Share (the “Purchase Price”).

3. The offering and sale of the Shares (the “Offering”) are being made pursuant to (a) an effective
Registration Statement on Form S-3 (including the base prospectus, dated June 22, 2007, contained
therein (the “Base Prospectus”) and the exhibits thereto and the documents incorporated therein by
reference, the “Registration Statement”) filed by the Company with the Securities and Exchange
Commission (the “Commission”), (b) if applicable, certain “free writing prospectuses” (as that term
is defined in Rule 405 under the Securities Act of 1933, as amended), that have been or will be
filed with the Commission by the Company and delivered to the Investor on or prior to the date
hereof, and (c) one or more preliminary prospectus supplements that have or will be filed with the
Commission and delivered to the Investor on or prior to the date hereof (together with the Base
Prospectus, collectively, the “Time of Sale Prospectus”), and (d) a final prospectus supplement
(the “Final Prospectus Supplement” and, together with the Time of Sale Prospectus, collectively,
the “Final Prospectus”) containing certain supplemental information regarding the Shares and terms
of the Offering that will be filed with the Commission and delivered, or otherwise made available
to the Investor by the filing of an electronic version thereof with the Commission, to the Investor
along with the Company’s counterpart to this Agreement.

4. The Company and the Investor agree that the Investor will purchase from the Company and the
Company will issue and sell to the Investor the Shares as set forth below for the aggregate
purchase price set forth below. The Shares shall be purchased pursuant to the Terms and Conditions
for Purchase of Shares attached hereto as Annex I and incorporated herein by this reference
as if fully set forth herein. The Investor acknowledges that the Offering is not being
underwritten by Oppenheimer & Co. Inc. (“Oppenheimer”) and KeyBanc Capital Markets Inc. (each, a
“Placement Agent” and, collectively, the “Placement Agents”) named in the Time of Sale Prospectus
as placement agents and that there is no minimum offering amount.

5. The manner of settlement of the Shares purchased by the Investor shall be determined by such
Investor as follows (check one):

	 	 	 
	[___] A.

	 	Delivery by electronic book-entry at The Depository Trust Company (“DTC”), registered in
the Investor’s name and address as set forth below, and released by U.S. Stock Transfer

 

 

Corporation, the Company’s transfer agent (the “Transfer Agent”), to the Investor at the
Closing. NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE
INVESTOR AND THE COMPANY, THE INVESTOR SHALL:

	 	(I)	 	DIRECT THE BROKER-DEALER AT WHICH THE ACCOUNT OR ACCOUNTS TO BE CREDITED
WITH THE SHARES ARE MAINTAINED TO SET UP A DEPOSIT/WITHDRAWAL AT CUSTODIAN (“DWAC”)
INSTRUCTING THE TRANSFER AGENT TO CREDIT SUCH ACCOUNT OR ACCOUNTS WITH THE SHARES,
AND
	 
	 	(II)	 	REMIT BY WIRE TRANSFER THE AMOUNT OF FUNDS EQUAL TO THE AGGREGATE
PURCHASE PRICE FOR THE SHARES BEING PURCHASED BY THE INVESTOR TO THE FOLLOWING
ACCOUNT:

	 	 	 	 	 	 	 
	 

	 	Escrow Agent:
	 	American Stock Transfer and Trust Company
	 	 
	 

	 	Bank Name:
	 	JPMorgan/Chase	 	 
	 

	 	ABA #
	 	021 000 021	 	 
	 

	 	Cust A/C #
	 	323 062 539	 	 
	 

	 	A/C Name
	 	American Stock Transfer
and Trust Company as Escrow Agent for Citizens, Inc.

—OR—

	 	 	 
	[___] B.

	 	Delivery versus payment (“DVP”) through DTC (i.e., the Company shall deliver Shares
registered in the Investor’s name and address as set forth below and released by the Transfer
Agent to the Investor at the Closing directly to the account(s) at Oppenheimer identified by
the Investor and simultaneously therewith payment shall be made from such account(s) to the
Company through DTC). NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS
AGREEMENT BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL:

	 	(I)	 	NOTIFY OPPENHEIMER OF THE ACCOUNT OR ACCOUNTS AT OPPENHEIMER TO BE
CREDITED WITH THE SHARES BEING PURCHASED BY SUCH INVESTOR, AND
	 
	 	(II)	 	CONFIRM THAT THE ACCOUNT OR ACCOUNTS AT OPPENHEIMER TO BE CREDITED WITH
THE SHARES BEING PURCHASED BY THE INVESTOR HAVE A MINIMUM BALANCE EQUAL TO THE
AGGREGATE PURCHASE PRICE FOR THE SHARES BEING PURCHASED BY THE INVESTOR.

—OR—

	 	 	 
	[___] C.

	 	Delivery to the Investor’s custodial account (i.e., the Company
shall deliver Shares registered in the Investor’s name and
address as set forth below and released by the Transfer Agent to
the Investor at the Closing directly to the account(s) at the
custodian identified by the Investor and promptly thereafter
payment shall be made to the Company). NO LATER THAN ONE (1)
BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE
INVESTOR AND THE COMPANY, THE INVESTOR SHALL NOTIFY OPPENHEIMER
OF THE ACCOUNT OR ACCOUNTS TO BE

 - 2 - 

 

	 	 	 
	 

	 	CREDITED WITH THE SHARES BEING PURCHASED BY SUCH INVESTOR AND THE CUSTODIAN AT WHICH SUCH
ACCOUNT OR ACCOUNTS ARE MAINTAINED.

IT IS THE INVESTOR’S RESPONSIBILITY TO (A) MAKE THE NECESSARY WIRE TRANSFER OR CONFIRM THE
PROPER ACCOUNT BALANCE IN A TIMELY MANNER AND (B) ARRANGE FOR SETTLEMENT IN A TIMELY MANNER. IF
THE INVESTOR DOES NOT DELIVER THE AGGREGATE PURCHASE PRICE FOR THE SHARES OR DOES NOT MAKE PROPER
ARRANGEMENTS FOR SETTLEMENT IN A TIMELY MANNER, THE SHARES MAY NOT BE DELIVERED AT CLOSING TO THE
INVESTOR OR THE INVESTOR MAY BE EXCLUDED FROM THE CLOSING ALTOGETHER.

6. The Investor represents that, except as set forth below, (a) it has had no position, office or
other material relationship within the past three years with the Company or persons known to it to
be affiliates of the Company, (b) it is not a NASD member or an Associated Person (as such term is
defined under the NASD Membership and Registration Rules Section 1011) as of the Closing, and
(c) neither the Investor nor any group of Investors (as identified in a public filing made with the
Commission) of which the Investor is a part in connection with the Offering of the Shares,
acquired, or obtained the right to acquire, 20% or more of the Common Stock (or securities
convertible into or exercisable for Common Stock) or the voting power of the Company on a
post-transaction basis. Exceptions:

 

(If no exceptions, write “none.” If left blank, response will be deemed to be “none.”)

7. The Investor represents that it has received, or has been able to obtain on the Commission’s
website, prior to or in connection with the receipt of this Agreement, (a) the Base Prospectus, and
the exhibits thereto and the documents incorporated therein by reference, (b) the Preliminary
Prospectus Supplement and (c) any free writing prospectuses that have been filed with the
Commission by the Company on or prior to the date hereof (collectively, the “Disclosure Package”),
along with the Company’s counterpart to this Agreement. The Investor acknowledges that, prior to
the delivery of this Agreement to the Company, the Investor will receive certain additional
information regarding the Offering, including pricing information (the “Offering Information”). The
Offering Information may be provided to the Investor by any means permitted under the Act,
including in the Final Prospectus Supplement, a free writing prospectus or oral communications.

8. The Company shall have the sole right to accept offers to purchase the Shares and may reject any
such offer, in its sole and absolute discretion, in whole or in part. No offer by the Investor to
buy Shares will be accepted and no part of the purchase price will be delivered to the Company
until the Company has accepted such offer by countersigning a copy of this Agreement, and any such
offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior
to the Company (or a Placement Agent on behalf of the Company) sending (orally, in writing or by
electronic mail) notice of its acceptance of such offer. An indication of interest in response to
the Investor signing this Agreement will involve no obligation or commitment of any kind until this
Agreement is accepted and countersigned by the Company and notice of such acceptance has been sent
as aforesaid.

[Signature Page Follows]

 - 3 - 

 

Number of Shares:                                              
                            

Aggregate Purchase Price: $                                                            

     Please confirm that the foregoing correctly sets forth the agreement between us by signing in
the space provided below for that purpose.

	 	 	 	 	 	 	 	 	 
	 	 	Dated as of: November ___, 2007	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	INVESTOR	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Print Name:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 	 	Address:	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 

Agreed and Accepted

this ___ day of November, 2007:

CITIZENS, INC.

	 	 	 	 	 
	By:
	 	 	 	 
	 

	 	 

Name:
	 	 
	 

	 	Title:	 	 

 - 4 - 

 

ANNEX I

TERMS AND CONDITIONS FOR PURCHASE OF SHARES

     1. Authorization and Sale of the Shares. Subject to the terms and conditions of this
Agreement, the Company has authorized the sale of the Shares.

     2. Agreement to Sell and Purchase the Shares; Placement Agents.

          2.1 At the Closing (as defined in Section 3.1), the Company will sell to the Investor,
and the Investor will purchase from the Company, upon the terms and conditions set forth herein,
the number of Shares set forth on the last page of the Agreement to which these Terms and
Conditions for Purchase of Shares are attached as Annex I (the “Signature Page”) for the
aggregate purchase price therefor set forth on the Signature Page.

          2.2 The Company proposes to enter into substantially this same form of Subscription Agreement
with certain other investors (the “Other Investors”), on the same material terms and conditions as
set forth herein. The Investor and the Other Investors are hereinafter sometimes collectively
referred to as the “Investors,” and this Agreement and the Subscription Agreements executed by the
Other Investors are hereinafter sometimes collectively referred to as the “Agreements.”

          2.3 Investor acknowledges that the Company has agreed to pay Oppenheimer & Co. Inc. and
KeyBanc Capital Markets Inc. (the “Placement Agents”) a fee (the “Placement Fee”) in respect of the
sale of Shares to the Investor.

          2.4 The Company has entered into a Placement Agent Agreement, dated November 28, 2007 (the
“Placement Agreement”), with the Placement Agents that contains certain representations,
warranties, covenants and agreements of the Company that may be relied upon by the Investor, which
shall be a third party beneficiary thereof. A copy of the Placement Agreement is available upon
request.

     3. Closings and Delivery of the Shares and Funds.

          3.1 Closing. The completion of the purchase and sale of the Shares (the “Closing”)
will occur at a place and time, to be no later than December 31, 2007 (the “Closing Date”), to be
specified by the Company and the Placement Agents, and of which the Investors will be notified in
advance by the Placement Agents. At the Closing, (a) the Company will cause the Transfer Agent to
deliver to the Investor the number of Shares set forth on the Signature Page registered in the name
of the Investor or, if so indicated on the Investor Questionnaire attached hereto as
Exhibit A, in the name of a nominee designated by the Investor, and (b) the aggregate
purchase price for the Shares being purchased by the Investor will be delivered by or on behalf of
the Investor to the Company.

          3.2 (a) Conditions to the Company’s Obligations. The Company’s obligation to issue
the Shares to the Investor will be subject to the receipt by the Company of the purchase price for
the Shares being purchased hereunder as set forth on the Signature Page and the accuracy of the
representations and warranties made by the Investor and the fulfillment of those undertakings of
the Investor to be fulfilled prior to the Closing Date.

 - 5 - 

 

               (b) Conditions to the Investor’s Obligations. The Investor’s obligation to purchase
the Shares will be subject to the conditions that (x) the representations and warranties of the
Company contained in the Placement Agreement shall be accurate in all material respects, and the
obligations of the Company to be fulfilled by it on or prior to the Closing contained herein and in
the Placement Agreement shall have been fulfilled, in all material respects, by the Company on or
prior to the Closing, and (y) the Placement Agents shall not have: (1) terminated the Placement
Agreement pursuant to the terms thereof or (2) determined that the conditions to the closing in the
Placement Agreement have not been satisfied. The Investor’s obligations are expressly not
conditioned on the purchase by any or all of the Other Investors of the Shares that they have
agreed to purchase from the Company.

          3.3 Delivery of Funds.

               (a) Delivery by Electronic Book-Entry at The Depository Trust Company. If the
Investor elects to settle the Shares purchased by such Investor through delivery by electronic
book-entry at DTC, no later than one (1) business day after the execution of this Agreement by
the Investor and the Company, the Investor shall remit by wire transfer the amount of funds
equal to the aggregate purchase price for the shares being purchased by the Investor to the
following account designated by the Company and the Placement Agents pursuant to the terms of that
certain Escrow Agreement (the “Escrow Agreement”) dated as of November 28, 2007, by and among the
Company, the Placement Agents and American Stock Transfer & Trust Company (the “Escrow Agent”):

	 	 	 	 	 	 	 
	 

	 	Escrow Agent:
	 	American Stock Transfer and Trust Company
	 	 
	 

	 	Bank Name:
	 	JPMorgan/Chase	 	 
	 

	 	ABA #
	 	021 000 021	 	 
	 

	 	Cust A/C #
	 	323 062 539	 	 
	 

	 	A/C Name
	 	American Stock Transfer
and Trust Company as Escrow Agent for Citizens, Inc.

               Such funds shall be held in escrow until the Closing and delivered by the Escrow Agent on
behalf of the Investors to the Company upon the satisfaction, in the sole judgment of the Placement
Agents, of the closing conditions set forth in Section 3.2(a) hereof. The Placement Agents
shall have no rights in or to any of the escrowed funds, unless the Placement Agents and the Escrow
Agent are notified in writing by the Company in connection with the Closing that a portion of the
escrowed funds shall be applied to the Placement Fee, as set forth in the Placement Agreement. The
Company shall indemnify and hold the Escrow Agent harmless from and against any and all losses,
costs, damages, expenses and claims (including, without limitation, court costs and reasonable
attorneys fees) (“Losses”) arising under this Section 3.3 or otherwise with respect to the
funds held in escrow pursuant hereto or arising under the Escrow Agreement, unless it is finally
determined that such Losses resulted directly from the willful misconduct or gross negligence of,
or a material breach of the Escrow Agreement by, the Escrow Agent. Anything in this Agreement to
the contrary notwithstanding, in no event shall the Escrow Agent be liable for any special,
indirect or consequential loss or damage of any kind whatsoever (including but not limited to lost
profits), even if the Escrow Agent has been advised of the likelihood of such loss or damage and
regardless of the form of action.

               The Investor shall also furnish to the Placement Agents a completed W-9 form (or, in the case
of an Investor who is not a United States citizen or resident, a W-8 form).

 - 6 - 

 

               (b) Delivery Versus Payment through The Depository Trust Company. If the Investor
elects to settle the Shares purchased by such Investor by delivery versus payment through DTC,
no later than one (1) business day after the execution of this Agreement by the Investor and
the Company, the Investor shall confirm that the account or accounts at Oppenheimer to be
credited with the Shares being purchased by the Investor have a minimum balance equal to the
aggregate purchase price for the Shares being purchased by the Investor.

          3.4 Delivery of Shares.

               (a) Delivery by Electronic Book-Entry at The Depository Trust Company. If the
Investor elects to settle the Shares purchased by such Investor through delivery by electronic
book-entry at DTC, no later than one (1) business day after the execution of this Agreement by
the Investor and the Company, the Investor shall direct the broker-dealer at which the account
or accounts to be credited with the Shares being purchased by such Investor are maintained, which
broker/dealer shall be a DTC participant, to set up a Deposit/Withdrawal at Custodian (“DWAC”)
instructing U.S. Stock Transfer Corporation, the Company’s transfer agent, to credit such account
or accounts with the Shares by means of an electronic book-entry delivery. Such DWAC shall
indicate the settlement date for the deposit of the Shares, which date shall be provided to the
Investor by Oppenheimer. Simultaneously with the delivery to the Company by the Escrow Agent of
the funds held in escrow pursuant to Section 3.3 above, the Company shall direct its
transfer agent to credit the Investor’s account or accounts with the Shares pursuant to the
information contained in the DWAC.

               (b) Delivery Versus Payment through The Depository Trust Company. If the Investor
elects to settle the Shares purchased by such Investor by delivery versus payment through DTC,
no later than one (1) business day after the execution of this Agreement by the Investor and
the Company, the Investor shall notify Oppenheimer of the account or accounts at Oppenheimer to
be credited with the Shares being purchased by such Investor. On the Closing Date, the Company
shall deliver the Shares to the Investor directly to the account(s) at Oppenheimer identified by
Investor and simultaneously therewith payment shall be made from such account(s) to the Company
through DTC.

     4. Representations, Warranties and Covenants of the Investor. The Investor represents and
warrants to, and covenants with, the Company and the Placement Agents that:

          4.1 (a) The Investor is knowledgeable, sophisticated and experienced in making, and is
qualified to make decisions with respect to, investments in shares presenting an investment
decision like that involved in the purchase of the Shares, including investments in securities
issued by the Company and investments in comparable companies, and has requested, received,
reviewed and considered all information it deemed relevant in making an informed decision to
purchase the Shares, (b) the Investor has answered all questions on the Signature Page and the
Investor Questionnaire attached hereto as Exhibit A for use in preparation of the Final
Prospectus Supplement and the answers thereto are true and correct as of the date hereof and will
be true and correct as of the Closing Date, and (c) in connection with its decision to purchase the
number of Shares set forth on the Signature Page, the Investor has received and is relying solely
upon the Disclosure Package and the documents incorporated by reference therein.

          4.2 The Investor has been informed, and acknowledges, that no action has been or will be taken
in any jurisdiction outside the United States by the Company or either Placement Agent that would
permit an offering of the Shares, or possession or distribution of offering materials in

 - 7 - 

 

connection with the issue of the Shares in any jurisdiction outside the United States where
action for that purpose is required. Each Investor outside the United States will comply with all
applicable laws and regulations in each foreign jurisdiction in which it purchases, offers, sells
or delivers Shares or has in its possession or distributes any offering material, in all cases at
its own expense. The Investor has been informed, and acknowledges, that the Placement Agents are
not authorized to make and have not made any representation or use of any information in connection
with the issue, placement, purchase and sale of the Shares, except as set forth or incorporated by
reference in the Disclosure Package and the Final Prospectus Supplement.

          4.3 (a) The Investor has full right, power, authority and capacity to enter into this
Agreement and to consummate the transactions contemplated hereby and has taken all necessary action
to authorize the execution, delivery and performance of this Agreement, and (b) this Agreement
constitutes a valid and binding obligation of the Investor enforceable against the Investor in
accordance with its terms, except as enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting
parties’ rights generally and except as enforceability may be subject to general principles of
equity (regardless of whether such enforceability is considered in a proceeding in equity or at
law).

          4.4 The Investor understands that nothing in this Agreement, the Disclosure Package, the Final
Prospectus Supplement or any other materials presented to the Investor in connection with the
purchase and sale of the Shares constitutes legal, tax or investment advice. The Investor has
consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed
necessary or appropriate in connection with its purchase of Shares.

          4.5 Since the date that is the tenth (10th) trading day prior to the date of this
Agreement, the Investor has not engaged in any transactions in the Company’s securities (including,
without limitation, any Short Sales (as defined below) of the Company’s securities), or established
or increased any “put equivalent position” as defined in Rule 16(a)-1(h) under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), with respect to the Company’s securities.
Each Investor covenants and agrees that it will not engage in any transactions in the Company’s
securities (including Short Sales) prior to the time that the transactions contemplated by this
Agreement are publicly disclosed. Each Investor covenants and agrees that it will not use any of
the Shares acquired pursuant to this Agreement to cover any short position in the Common Stock if
doing so would be in violation of applicable securities laws.

          For purposes hereof, the term “Short Sales” includes, without limitation, all “short sales” as
defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against
the box, and all types of direct and indirect stock pledges, forward sales contracts, options,
puts, calls, short sales, swaps, “put equivalent positions” (as defined in Rule 16a-1(h) under the
Exchange Act) and similar arrangements (including on a total return basis), and sales and other
transactions through non-US broker dealers or foreign regulated brokers.

     5. Representations, Warranties and Covenants of the Company. The Company represents and
warrants to, and covenants with, the Investor and the Placement Agents that:

          5.1 The Company has full right, corporate power, authority and capacity to enter into this
Agreement and to consummate the transactions contemplated hereby and has taken all necessary action
to authorize the execution, delivery and performance of this Agreement. This Agreement constitutes
a valid and binding obligation of the Company enforceable against the

 - 8 - 

 

Company in accordance with its terms, except as enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and
contracting parties’ rights generally and except as enforceability may be subject to general
principles of equity (regardless of whether such enforceability is considered in a proceeding in
equity or at law). The performance of this Agreement and the consummation of the transactions
contemplated hereby will not result in the creation or imposition of any lien, charge or
encumbrance upon any of the assets of the Company or any of its subsidiaries pursuant to the terms
or provisions of, or result in a breach or violation of any of the terms or provisions of, or
conflict with or constitute a default under, or give any party a right to terminate any of its
obligations under, or result in the acceleration of any obligation under, the certificate or
articles of incorporation or by-laws (or any analogous documents) of the Company or any subsidiary,
any indenture, mortgage, deed of trust, voting trust agreement, loan agreement, bond, debenture,
note agreement or other evidence of indebtedness, or any material lease, contract or other
agreement or instrument to which the Company or any subsidiary is a party or by which the Company
or any subsidiary, or any of their respective properties, is bound, or, to its knowledge, violate
or conflict with any judgment, ruling, decree, order, statute, rule or regulation of any court or
other governmental agency or body applicable to the business or properties of the Company or any
subsidiary.

          5.2 The Registration Statement was declared effective by the Commission on June 22, 2007. The
Registration Statement is effective on the date hereof and the Company has not received notice that
the Commission has issued or intends to issue a stop order with respect to the Registration
Statement or that the Commission otherwise has suspended or withdrawn the effectiveness of the
Registration Statement, either temporarily or permanently, or intends or has threatened in writing
to do so. The “Plan of Distribution” section in the Time of Sale Prospectus describes the issuance
and sale of the Shares. Each part of the Registration Statement, when it became effective, did not
contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein not misleading. As of the date
the Base Prospectus, or any amendment or supplement to the Base Prospectus, was or is filed with
the Commission and at the Closing Date, the Base Prospectus or any amendment or supplement thereto,
did not and will not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein, in the light of the circumstances under which they
were made, not misleading.

          5.3 The Company shall (i) before the opening of trading on the New York Stock Exchange on the
next trading day after the date hereof, issue a press release, announcing the Offering and
disclosing all material aspects of the transactions contemplated hereby, and (ii) make such other
filings and notices in the manner and time required by the Commission with the respect to the
Offering and the transactions contemplated hereby. The Company shall not identify the Investor by
name in any press release or public filing, or otherwise publicly disclose the Investor’s name,
without the Investor’s prior, written consent, unless required by law or the rules and regulations
of any self-regulatory organization to which the Company or its securities are subject.

     6. Survival of Representations, Warranties and Agreements. Notwithstanding any investigation
made by any party to this Agreement or by the Placement Agents, all covenants, agreements,
representations and warranties made by the Company and the Investor herein will survive the
execution of this Agreement, the delivery to the Investor of the Shares being purchased and the
payment therefor. The Placement Agents shall be third party beneficiaries with respect to the
representations, warranties and agreements of the Investor in Section 4 hereof and the Company in
Section 5 hereof.

 - 9 - 

 

     7. From the date hereof until the date that is 90 days after the Closing Date, the Company
will not, directly or indirectly, offer, sell, assign, transfer, pledge, or contract to sell any
shares of Common Stock or securities convertible into or exchangeable or exercisable for shares of
Common Stock, except that (a) the Company may engage in transactions as provided in the Placement
Agent Agreement or as consented to in advance by Oppenheimer and (b) the Company may pay dividends
to the holders of the Series A-1 Senior Convertible Preferred Stock and/or the Series A-2 Senior
Convertible Preferred Stock of the Company in the form of Common Stock pursuant to, and in
accordance with, the Amendment to State Series, dated as of July 12, 2004, of the Company, as in
effect as of the date hereof.

     8. Notices. All notices, requests, consents and other communications hereunder will be in
writing, will be mailed (a) if within the domestic United States by first-class registered or
certified airmail, or nationally recognized overnight express courier, postage prepaid, or by
facsimile or (b) if delivered from outside the United States, by International Federal Express or
facsimile, and will be deemed given (i) if delivered by first-class registered or certified mail
domestic, three business days after so mailed, (ii) if delivered by nationally recognized overnight
carrier, one business day after so mailed, (iii) if delivered by International Federal Express, two
business days after so mailed and (iv) if delivered by facsimile, upon electric confirmation of
receipt and will be delivered and addressed as follows:

	 	 	 
	(a)
	 	if to the Company, to:
	 
	 	 
	 
	 	Citizens, Inc.
	 
	 	400 East Anderson Lane
	 
	 	Austin, Texas 78752
	 
	 	Attention:  Rick D. Riley
	 
	 	Phone:                   (512) 837-7100
	 
	 	Telecopy:                (512) 836-9785
	 
	 	 
	 
	 	with copies (for informational purposes only) to:
	 
	 	 
	 
	 	JONES & KELLER, P.C.
	 
	 	1625 Broadway, 16th Floor
	 
	 	Denver, CO 80202
	 
	 	Attention:  Reid Godbolt
	 
	 	Phone: (303) 573-1600
	 
	 	Telecopy: (303) 573-0769

               (b) if to the Investor, at its address on the Signature Page hereto, or at such other address
or addresses as may have been furnished to the Company in writing.

     9. Changes. This Agreement may not be modified or amended except pursuant to an instrument in
writing signed by the Company and the Investor.

     10. Headings. The headings of the various sections of this Agreement have been inserted for
convenience of reference only and will not be deemed to be part of this Agreement.

 - 10 - 

 

     11. Severability. In case any provision contained in this Agreement should be invalid,
illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining
provisions contained herein will not in any way be affected or impaired thereby.

     12. Governing Law. This Agreement will be governed by, and construed in accordance with, the
internal laws of the State of New York, without giving effect to the principles of conflicts of law
that would require the application of the laws of any other jurisdiction.

     13. Counterparts. This Agreement may be executed in two or more counterparts, each of which
will constitute an original, but all of which, when taken together, will constitute but one
instrument, and will become effective when one or more counterparts have been signed by each party
hereto and delivered to the other parties. The Company and the Investor acknowledge and agree that
the Company shall deliver its counterpart to the Investor along with the Final Prospectus
Supplement.

     14. Confirmation of Sale. The Investor acknowledges and agrees that such Investor’s receipt
of the Company’s counterpart to this Agreement, together with the Final Prospectus Supplement,
shall constitute written confirmation of the Company’s sale of Shares to such Investor.

     15. Termination. In the event that the Placement Agreement is terminated by the Placement
Agents pursuant to the terms thereof, this Agreement shall terminate without any further action on
the part of the parties hereto.

 - 11 - 

 

Exhibit A

CITIZENS, INC.

INVESTOR QUESTIONNAIRE

     Pursuant to Section 3 of Annex I to the Agreement, please provide us with the
following information:

	 	 	 	 	 	 	 
	1.

	 	The exact name that your Shares are to be registered in. You may
use a nominee name if appropriate:	 	 	 	 
	 

	 	 	 	 

	 	 
	2.

	 	The relationship between the Investor and the registered holder
listed in response to item 1 above:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	3.

	 	The mailing address of the registered holder listed in response to
item 1 above:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	4.

	 	The Social Security Number or Tax Identification Number of the
registered holder listed in the response to item    1 above:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	5.

	 	Name of DTC Participant (broker-dealer at which the account or
accounts to be credited with the Shares are    maintained):	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	6.

	 	DTC Participant Number:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	7.

	 	Name of Account at DTC Participant being credited with the Shares:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	8.

	 	Account Number at DTC Participant being credited with the Shares:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}]]